Imagion Biosystems Ltd. (AU:IBX) has released an update.
Imagion Biosystems Ltd., listed as ASX:IBX, announces a significant advancement in cancer detection with their proprietary MagSense® Technology, a molecular magnetic resonance imaging innovation. This breakthrough promises to enhance diagnostic precision, offering a new tool for personal and clinical use in the fight against cancer.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.